IVI-RMA Global→KKR
Acquisition · Cash (leveraged buyout) · announced Mar 1, 2022
Announced
Mar 1, 2022
Closed
Jan 18, 2023
Economics
Cash (leveraged buyout)()
Pre-deal · pre-deal mark: 2022, year precision · rounding grid ±$100M · KKR press release — IVI-RMA Global acquisition, 2023
~€3B ($3.25B) for 80% stake; world's largest fertility clinic acquisition; founders retained 20%
Target
IVI-RMA Global
Fertility · Fertility science
HQ Valencia, Spain · Founded 1990
World's largest fertility clinic network; 75+ clinics and 28 labs in 9 countries; formed from 2017 merger of Spain's IVI and US-based RMANJ
- Axios Pro (April 13, 2022) - deal announcement
- Fertility Bridge (January 26, 2023) - deal close confirmation
- Spanish CNMC regulatory approval (December 21, 2022)
Acquirer
KKR
Healthcare
HQ New York, NY
Global investment firm; major investor in fertility clinic consolidation
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Created world's largest fertility services group by combining IVI-RMA with KKR's prior GeneraLife acquisition; 75+ clinics in 9 countries
Evidence ladder
Tertiary (trade / analyst)
Axios Pro (April 13, 2022)
Tertiary (trade / analyst)
Fertility Bridge (January 26, 2023)
Tertiary (trade / analyst)
CNMC approval (December 21, 2022)
Limitations
- Citations are press/IR only — two wires of the same announcement are not dual-source. Add a primary filing.
- ~€3B ($3.25B) for 80% stake; world's largest fertility clinic acquisition; founders retained 20%
- Pre-deal valuation sourced from: KKR press release — IVI-RMA Global acquisition, 2023. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Same-sector adjacency — not valuation peers
These deals share the sector tag and window but sit outside the 0.25×–4× value band. The dataset keeps them for clinical adjacency, not as price comps.
| Target | Acquirer | Announced | Value | Vs this deal |
|---|---|---|---|---|
| Indira IVF | BPEA EQT | Jul 28, 2023 | ||
| Eugin Group (North American operations) | KKR (via IVI-RMA) | Nov 1, 2023 | ||
| Hamilton Thorne | Astorg | Jul 22, 2024 | ||
| Modern Fertility | Ro | May 19, 2021 |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — IVI-RMA Global (Fertility). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 3 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.